Cargando…
Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137
BACKGROUND: The incidence of colon cancer (CC) is currently high, and is mainly treated with chemotherapy. Oxaliplatin (L-OHP) is a commonly used drug in chemotherapy; however, long-term use can induce drug resistance and seriously affect the prognosis of patients. Therefore, this study investigated...
Autores principales: | Liang, Jing, Tian, Xiao-Feng, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152514/ https://www.ncbi.nlm.nih.gov/pubmed/32308348 http://dx.doi.org/10.3748/wjg.v26.i13.1474 |
Ejemplares similares
-
Downregulation of long non‐coding RNA Opa interacting protein 5‐antisense RNA 1 inhibits breast cancer progression by targeting sex‐determining region Y‐box 2 by microRNA‐129‐5p upregulation
por: Zeng, Huijuan, et al.
Publicado: (2018) -
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
por: Malik, Juliane, et al.
Publicado: (2022) -
MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
por: Setijono, Stephanie Rebecca, et al.
Publicado: (2018) -
MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
por: Elemeery, Moustafa Nouh, et al.
Publicado: (2019) -
Long non-coding RNA VIM Antisense RNA 1 (VIM-AS1) sponges microRNA-29 to participate in diabetic retinopathy
por: Zeng, Feng, et al.
Publicado: (2020)